Skip to main content
. 2018 Nov 21;24(43):4939–4949. doi: 10.3748/wjg.v24.i43.4939

Table 3.

Human leukocyte antigen-DRB1* and human leukocyte antigen-DQB1* alleles in donors and recipients, association with recurrent primary sclerosing cholangitis n (%)

Donor rPSC P value Recipient rPSC P value
HLA-DRB1*
1 5 2 (40.0) 1.000 9 3 (33.3) 0.711
3 7 2 (28.6) 0.427 23 11 (47.8) 0.767
4 9 4 (44.4) 1.000 6 0 (0) 0.029
5 1 1 (100) 0.450
6 2 2 (100) 0.196
7 15 10 (66.7) 0.050 2 0 (0) 0.498
8 2 1 (50.0) 1.000
9 1 0 (0) 1.000 1 1 (100) 0.435
10 1 1 (100) 0.435
11 10 4 (40.0) 1.000 5 1 (20.0) 0.369
12 2 2 (100) 0.196 1 1 (100) 0.435
13 8 2 (25.0) 0.258 10 5 (50.0) 0.726
14 4 0 (0) 0.114 1 1 (100) 0.435
15 8 3 (37.5) 0.709 15 5 (33.3) 0.365
16 1 1 (100) 0.450 3 2 (66.7) 0.572
HLA-DQB1*
2 17 9 (53.0) 0.740 25 10 (40.0) 1.000
3 20 8 (40.0) 0.740 11 1 (9.1) 0.030
7 15 6 (40.0) 0.500 7 0 (0) 0.031
8 7 5 (71.4) 0.229 4 0 (0) 0.140
9 2 1 (50.0) 1.000 1 1 (100) 0.395
4 2 1 (50.0) 1.000
5 9 4 (44.4) 1.000 10 5 (50.0) 0.481
6 13 4 (30.8) 0.164 21 9 (42.9) 0.760

rPSC: Recurrent primary sclerosing cholangitis.